Monica Dinulescu

591 total citations
12 papers, 90 citations indexed

About

Monica Dinulescu is a scholar working on Oncology, Molecular Biology and Aerospace Engineering. According to data from OpenAlex, Monica Dinulescu has authored 12 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Aerospace Engineering. Recurrent topics in Monica Dinulescu's work include Melanoma and MAPK Pathways (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Polyomavirus and related diseases (2 papers). Monica Dinulescu is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Polyomavirus and related diseases (2 papers). Monica Dinulescu collaborates with scholars based in France, United States and Australia. Monica Dinulescu's co-authors include H. Adamski, François Le Gall, Alain Dupuy, Élisabeth Polard, Thierry Lesimple, Emmanuel Oger, A. Dupuy, Sandrine Kerbrat, F. Poizeau and Marc Pracht and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Monica Dinulescu

12 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Dinulescu France 7 52 32 14 12 12 12 90
María Jesús Rubio-Pérez Spain 6 86 1.7× 31 1.0× 12 0.9× 12 1.0× 8 0.7× 15 137
Valérie Schuermans Netherlands 6 36 0.7× 47 1.5× 13 0.9× 36 3.0× 15 1.3× 19 155
Zhongcai Wu China 4 50 1.0× 64 2.0× 5 0.4× 9 0.8× 10 0.8× 5 125
Athena Hatzimihalis Australia 4 48 0.9× 37 1.2× 4 0.3× 2 0.2× 15 1.3× 9 76
J.-P. Arnault France 4 30 0.6× 18 0.6× 5 0.4× 6 0.5× 13 1.1× 11 65
Astrid Irwanto Singapore 7 28 0.5× 39 1.2× 25 1.8× 4 0.3× 4 0.3× 13 130
Anne Menz Germany 4 18 0.3× 44 1.4× 14 1.0× 5 0.4× 8 0.7× 13 78
D Alazawi Ireland 3 40 0.8× 31 1.0× 9 0.6× 16 1.3× 34 2.8× 6 107
Shuqun Zhang China 6 26 0.5× 31 1.0× 6 0.4× 2 0.2× 9 0.8× 9 70
N. Iglesias-Pena Spain 6 56 1.1× 16 0.5× 2 0.2× 27 2.3× 7 82

Countries citing papers authored by Monica Dinulescu

Since Specialization
Citations

This map shows the geographic impact of Monica Dinulescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Dinulescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Dinulescu more than expected).

Fields of papers citing papers by Monica Dinulescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Dinulescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Dinulescu. The network helps show where Monica Dinulescu may publish in the future.

Co-authorship network of co-authors of Monica Dinulescu

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Dinulescu. A scholar is included among the top collaborators of Monica Dinulescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Dinulescu. Monica Dinulescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Poizeau, F., Frédéric Balusson, F. Lemaı̂tre, et al.. (2023). The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma. British Journal of Dermatology. 188(4). 482–490. 2 indexed citations
2.
Kervarrec, Thibault, Yannick Le Corre, Charlée Nardin, et al.. (2023). Impact of adjuvant radiation therapy on survival and recurrence in patients with stage I-III Merkel cell carcinoma: A retrospective study of 312 patients. Journal of the American Academy of Dermatology. 89(4). 824–826. 1 indexed citations
3.
Dinulescu, Monica, Jean‐Michel Nguyen, H. Maillard, et al.. (2023). Efficacy of imiquimod in the management of lentigo maligna. Journal of the European Academy of Dermatology and Venereology. 37(9). 1785–1791. 4 indexed citations
4.
Poizeau, F., Sandrine Kerbrat, Frédéric Balusson, et al.. (2022). The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving Immunotherapy. JNCI Journal of the National Cancer Institute. 114(5). 686–694. 13 indexed citations
5.
Campillo‐Gimenez, Boris, Marc Pracht, M. Porneuf, et al.. (2021). Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodies. Melanoma Research. 31(3). 208–217. 6 indexed citations
6.
Poizeau, F., Sandrine Kerbrat, André Happe, et al.. (2020). Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017. Journal of Investigative Dermatology. 141(4). 830–839.e3. 8 indexed citations
7.
Delord, Jean‐Pierre, Antoîne Italiano, Ahmad Awada, et al.. (2020). Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors. Targeted Oncology. 16(1). 37–46. 8 indexed citations
8.
Lebbé, Célèste, Antoîne Italiano, Nadine Houédé, et al.. (2020). Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial. Targeted Oncology. 16(1). 47–57. 10 indexed citations
9.
Kervarrec, Thibault, Agnès Caille, Yannick Le Corre, et al.. (2020). Narrow resection margins are not associated with mortality or recurrence in patients with Merkel cell carcinoma: A retrospective study. Journal of the American Academy of Dermatology. 84(4). 921–929. 11 indexed citations
10.
Dupuy, A., Monica Dinulescu, C. Droitcourt, et al.. (2017). Do the Side Effects of BRAF Inhibitors Mimic RASopathies?. Journal of Investigative Dermatology. 137(4). 805–809. 5 indexed citations
11.
Dinulescu, Monica, et al.. (2012). Enoxaparin-Induced DRESS Syndrome. Case Reports in Dermatology. 4(3). 233–237. 19 indexed citations
12.
Miquel, J., et al.. (2009). Hypercalcémie aiguë et carcinomes épidermoïdes multiples compliquant une hidradénite suppurée. La Presse Médicale. 38(7-8). 1177–1180. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Jesús Rubio-Pérez Breakdown of academic impact, for papers by Valérie Schuermans Breakdown of academic impact, for papers by Zhongcai Wu Breakdown of academic impact, for papers by Athena Hatzimihalis Breakdown of academic impact, for papers by J.-P. Arnault Breakdown of academic impact, for papers by Astrid Irwanto Breakdown of academic impact, for papers by Anne Menz Breakdown of academic impact, for papers by D Alazawi Breakdown of academic impact, for papers by Shuqun Zhang Breakdown of academic impact, for papers by N. Iglesias-Pena
Rankless by CCL
2026